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Background: Indoxyl sulfate, a uremic toxin, is accumulated in the serum of chronic kidney disease (CKD) patients,
accelerating the progression of CKD. In CKD rat kidney, the expressions of nuclear factor (erythroid-derived 2)-like 2
(Nrf2) and its related genes are downregulated. AST-120, an oral sorbent, reduces serum indoxyl sulfate and slows
the progression of CKD. The present study aimed to determine whether indoxyl sulfate downregulates Nrf2
expression in human proximal tubular cells and rat kidneys and whether AST-120 upregulates Nrf2 expression in
CKD rat kidneys.
Methods: Effects of indoxyl sulfate on expression of Nrf2 were determined using HK-2 cells as human proximal
tubular cells and the following animals: (1) Dahl salt-resistant normotensive rats (DN), (2) Dahl salt-resistant
normotensive indoxyl sulfate-administered rats (DN+IS), (3) Dahl salt-sensitive hypertensive rats (DH), and (4) Dahl
salt-sensitive hypertensive indoxyl sulfate-administered rats (DH+IS). Further, AST-120 was administered to subtotally
nephrectomized CKD rats to determine its effect on the expression of Nrf2.
Results: Indoxyl sulfate downregulated Nrf2 expression in HK-2 cells. The indoxyl sulfate-induced downregulation of
Nrf2 expression was alleviated by an inhibitor of nuclear factor-κB (NF-κB) (pyrrolidine dithiocarbamate) and small
interfering RNA specific to NF-κB p65. DN+IS, DH, and DH+IS rats showed decreased renal expression of Nrf2 and
its downstream target genes, heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase 1 (NQO1), and
increased renal expression of 8-hydroxydeoxyguanosine (8-OHdG), a marker of reactive oxygen species (ROS),
compared with DN. Thus, indoxyl sulfate, as well as hypertension, downregulated renal expression of Nrf2 in rats.
AST-120 upregulated renal expression of Nrf2, HO-1 and NQO1 and suppressed renal expression of 8-OHdG
compared with control CKD rats.
Conclusions: Indoxyl sulfate downregulates renal expression of Nrf2 through activation of NF-κB, followed by
downregulation of HO-1 and NQO1 and increased production of ROS. Further, AST-120 upregulates renal
expression of Nrf2 in CKD rats by removing serum indoxyl sulfate, followed by upregulation of HO-1 and NQO1 and
decreased production of ROS.
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Indoxyl sulfate, a uremic toxin, accelerates the progression
of chronic kidney disease (CKD). Indoxyl sulfate is a me-
tabolite of tryptophan in dietary proteins and is synthe-
sized in the liver from indole that is produced by intestinal
flora including Escherichia coli. Indoxyl sulfate is normally
excreted into urine. As renal function deteriorates, how-
ever, indoxyl sulfate accumulates in serum due to its re-
duced renal clearance [1,2]. Accumulated indoxyl sulfate
in serum is incorporated into the basolateral membrane of
renal proximal tubular cells by mediating organic anion
transporter types 1 and 3 [3]. Indoxyl sulfate induces cel-
lular senescence and dysfunction of kidneys and proximal
tubular cells [4-12]. Indoxyl sulfate induces reactive
oxygen species (ROS) which activates nuclear factor-κB
(NF-κB) and p53 [9-11]. Subsequently, indoxyl sulfate
induces renal expression of fibrotic genes such as
transforming growth factor-β1 (TGF-β1) [4,5] and α-
smooth muscle actin (α-SMA) [9,10], inflammatory genes
such as monocyte chemotactic protein-1 (MCP-1) [11],
and cellular senescence [9,10], and suppresses renal ex-
pression of Klotho [8]. AST-120, an oral sorbent, de-
creases serum level of indoxyl sulfate by adsorbing indole,
a precursor of indoxyl sulfate, in the intestine [13-17], and
thereby suppresses progression of CKD.
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a
basic leucine zipper transcription factor, and regulates
induction of numerous antioxidant and phase II detoxi-
fying enzymes [18]. Nrf2 is usually localized in the cyto-
plasm and associated with a repressor molecule known
as Kelch-like ECH-associating protein 1 (Keap1), which
facilitates its ubiquitination with subsequent degradation
[19]. Keap1 contains several reactive cysteine residues
that serve as sensors of intracellular redox state. There
are two pools of Nrf2 proteins, free floating Nrf2 (fNrf2)
and Keap1-binding Nrf2 (kNrf2). Nrf2 signaling is re-
pressed by Keap1 at basal condition and induced by
oxidative stress. Oxidative stress can impede Keap1-
mediated Nrf2 ubiquitination but fail to disrupt Nrf2/
Keap1 binding. When stimulated by oxidative stress, the
ubiquitination and the proteasomal degradation are
inhibited. Keap1 is saturated by undegradated kNrf2.
However, protein translation is elevated. In combination,
the pool of fNrf2 expands. fNrf2 can sense the change of
redox milieu and transmit redox signals to cell nucleus
via gradient nuclear translocation [19]. Nrf2 translocates
to the nucleus and binds to an antioxidant response
element (ARE), followed by transcriptional induction of
ARE-bearing genes that encode antioxidative and detoxi-
fying proteins such as heme oxygenase-1 (HO-1) and
NAD(P)H:quinone oxidoreductase 1 (NQO1) [18]. The
deletion of Nrf2 in murine models results in structural
and functional kidney defects that are associated with in-
creased inflammation and oxidative stress [18].HO-1 catalyzes the first and rate limiting enzyme step
of heme degradation and produces carbon monoxide
(CO), iron and biliverdin, which is converted into biliru-
bin via biliverdin reductase. The expression of HO-1 is
upregulated by a variety of oxidative stress stimuli as an
adaptive cellular response against the toxicity of oxida-
tive stress. The deletion of HO-1 in murine unilateral ur-
eteral obstruction models promotes epithelial-mesenchymal
transition, renal fibrosis, and apoptosis [20]. NQO1 cata-
lyzes the oxidation of NAD(P)H to NAD(P)+ by various
quinones. Activation of NQO1 leads to diminished renal
damage through reduced oxidative stress by mediating
NADPH oxidase activity via modulation of the cellular
NAD(P)H:NAD(P)+ ratio in Dahl salt-sensitive rats on a
high-salt diet [21].
The expressions of Nrf2 and its downstream target genes
such as HO-1 and NQO1 are impaired in the kidneys of
CKD rats [22]. The present study aimed to determine
whether indoxyl sulfate is involved in downregulation of
Nrf2 functions in kidneys, and how indoxyl sulfate
regulates Nrf2 expression in proximal tubular cells. Fur-
thermore, the present study aimed to determine whether
AST-120 increases renal expression of Nrf2 in CKD rats.
Methods
Reagents
Reagents were obtained from the following suppliers:
rabbit polyclonal anti-Nrf2 (sc-722) for immunohisto-
chemistry and immunoblotting, Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA); rabbit polyclonal anti-HO-1
(ab13243) for immunohistochemistry, Abcam (Cam-
bridge, UK); rabbit polyclonal anti-NQO1 (ab34173) for
immunohistochemistry, Abcam (Cambridge, UK); mouse
monoclonal anti-8-hydroxydeoxyguanosine (8-OHdG)
(MOG-020P) for immunohistochemistry, Japan Institute
for the Control of Aging, NIKKEN SEIL, (Shizuoka, Japan);
anti-α-tubulin for immunoblotting, Calbiochem (La Jolla,
CA, USA); anti-rabbit IgG horseradish peroxidase (HRP)-
linked antibody, anti-mouse IgG, HRP-linked antibodies,
Cell Signaling Technology (Beverly, MA, USA); indoxyl sul-
fate, Alfa Aesar (Lancashire, UK); pyrrolidine dithiocarba-
mate (PDTC) (an inhibitor of NF-κB), Sigma chemical (St.
Louis, MO, USA); Dulbecco's modified Eagle's medium
(DMEM)/F12, Wako (Osaka, Japan); trypsin-EDTA, fetal
bovine serum (FBS), and insulin-transferrin-selenium,
GIBCO (Grand Island, NY, USA); penicillin and strepto-
mycin, Nacalai Tesque (Kyoto, Japan).
Cell culture
HK-2 cells (human proximal tubular cells) purchased from
ATCC (Manassas, VA, USA) were maintained in DMEM/
F12 supplemented with 10% FBS, insulin (10 μg/ml insulin-
transferrin (5.5 μg/ml)-selenium (6.7 ng/ml), 100 U/ml
































Figure 1 Indoxyl sulfate decreases Nrf2 expression in HK-2
cells. A: serum-starved HK-2 cells were incubated with or without
indoxyl sulfate (250 μM) for 48 h. Expression levels of Nrf2 mRNA
were measured by real-time PCR. Data are expressed as mean±SE
(n=4). *P < 0.05 vs. untreated cells. B: experimental conditions were
as described in A except treatment with indoxyl sulfate for 72 h was
used in place of 48 h. Whole cell lysates were immunoblotted using
anti-Nrf2 antibody.
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p65
Knockdown analysis was performed as described previ-
ously [10]. The sense sequence of the siRNA for NF-κB
p65 was: 5’-AGAGGACAUUGAGGUGUAUdTdT-3’.
Quantitative real time PCR
Quantitative real time PCR was performed as described
previously [8-11]. Oligonucleotide primers were: human




The expression of mRNA levels was measured as the ratio
of each mRNA to GAPDH mRNA.
Immunoblotting
Immunoblotting was performed as described previously
[12]. Nrf2 and p65 were detected using specific anti-
bodies and normalized to α-tubulin. The protein bands
were visualized using the enhanced Chemi-Lumi One
system (Nacalai Tesque).
Animal study 1
Experimental rats were produced as reported previ-
ously [6]. Five-week-old Dahl salt-resistant rats
(Dahl-Iwai, n = 16) and Dahl salt-sensitive rats (Dahl-
Iwai, n = 16) were purchased from Japan SLC, Inc. (Ha-
mamatsu, Shizuoka, Japan), and were fed powder rat chow
(CE-2, Clea, Tokyo, Japan) and water for 2 weeks. Later,
the rats were fed the chow (CE-2) with salt (1.5% NaCl)
dissolved in the water. At 16 weeks of age, Dahl salt-
sensitive rats spontaneously developed hypertension with
systolic blood pressure (BP) of >140 mm Hg; and the rats
were divided into the following 2 groups: Dahl salt-
resistant normotensive rats (DN, n=16) and Dahl salt-
sensitive hypertensive rats (DH, n = 16), and then rats were
further randomized into 2 groups: control rats and in-
doxyl sulfate-administered rats (200 mg/kg/day of indoxyl
sulfate in water). Therefore, the 4 groups were as fol-
lows: (1) Dahl salt-resistant normotensive rats (DN,
n=8), (2) Dahl salt-resistant normotensive indoxyl
sulfate-administered rats (DN + IS, n=8), (3) Dahl salt-
sensitive hypertensive rats (DH, n=8), and (4) Dahl salt-
sensitive hypertensive indoxyl sulfate-administered rats
(DH + IS, n=8). At 48 weeks of age (32nd week of the
study), kidney tissues were excised for immunohisto-
chemical analysis. Serum indoxyl sulfate levels were
measured by high-performance liquid chromatography
[23,24].
Animal study 2
Experimental rats were produced as reported previously
[17]. Seven-week old male Sprague-Dawley rats (Clea,Tokyo, Japan) were used to produce CKD rats by 4/5-
nephrectomy. In the first session, while the renal artery
and vein of the left kidney were ligated, three-fifths of
the left kidney was removed with a razor, and thrombin
was applied onto the cut surface for hemostasis. Then,
the artery and vein of the left kidney were unligated.
One week after the first operation, the right kidney was
removed after ligation of the renal artery and vein. These
operations were performed under anesthesia with so-
dium pentobarbital (Schering-Plough, Corp., NJ, USA).
Eleven weeks after subtotal nephrectomy, the rats were
randomized into two groups, control CKD rats (n=9),
and AST-120-treated CKD rats (n=9). AST-120 was or-
ally administered to the rats at a dose of 4 g/kg/day with
powder chow (CE-2, Clea) for 10 weeks, whereas powder
chow alone was administered to control CKD rats. A
control CKD rat died of uremia. Normal rats (n=9) were
used to compare the data with CKD rats.
The Animal Care Committee of Kureha Biomedical
Research Laboratories approved these animal studies
(1 and 2), which proceeded according to the Guiding
Principles for the Care and Use of Laboratory Ani-




































Figure 2 An inhibitor of NF-κB alleviates indoxyl sulfate-induced decrease of Nrf2 expression in HK-2 cells. A: serum-starved HK-2 cells
were incubated with or without PDTC (10 μM) for 30 min, followed by indoxyl sulfate (250 μM) for 48 h. Expression levels of Nrf2 mRNA were
measured by real-time PCR. Data are expressed as mean±SE (n=4). *P < 0.05 vs. indoxyl sulfate-treated cells without PDTC. B: experimental
conditions were as described in A except treatment with indoxyl sulfate for 72 h was used in place of 48 h. Whole cell lysates were
immunoblotted using anti-Nrf2 antibody.
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Immunohistochemistry of Nrf2, HO-1 and 8-OHdG
was performed using the streptavidin-biotin complex
(SABC) method as described previously [7,17]. Sec-
tions were incubated with the primary antibody
(Nrf2, 1:100; HO-1, 1:50; NQO1, 1:100; 8-OHdG
1:20). Immunostaining positive areas were quantified
in 10 random sections in the renal cortex using NIH
Image 1.62.
Statistical analysis
Data are expressed as mean±SE. The differences in im-
munohistochemical values were analyzed by Fisher’s
least significant difference (LSD) test of ANOVA. To
compare values between two groups, Student’s t test was
used. Results were considered statistically significant
when the P value was less than 0.05.
Results
Indoxyl sulfate downregulates Nrf2 expression in human
proximal tubular cells through activation of NF-κB
HK-2 cells were cultured with or without indoxyl
sulfate at a concentration of 250 μM which is com-
parable to its mean serum level in patients on
hemodialysis [1]. Indoxyl sulfate-treated cells showed
significantly reduced both mRNA and protein ex-
pressions of Nrf2 as compared with untreated cells(Figure 1). Thus, indoxyl sulfate decreased Nrf2 ex-
pression in HK-2 cells. Because the expression of
Nrf2 protein in the whole cell lysates was reduced,
the expressions of its downstream genes are consid-
ered to be decreased.
Indoxyl sulfate activates NF-κB in HK-2 cells as
reported previously [10]. In the present study, we used
PDTC to examine relationship between NF-κB activation
and Nrf2 expression. PDTC blocks degradation of IκB
and thereby inhibit NF-κB activity. PDTC alleviated in-
doxyl sulfate-induced downregulation of both Nrf2
mRNA and protein expression (Figure 2). We further
confirmed these results with NF-κB p65 siRNA. The ex-
pression of NF-κB p65 was reduced by its siRNA
(Figure 3). Indoxyl sulfate-induced downregulation of
both Nrf2 mRNA and protein expression was relieved
by NF-κB p65 siRNA as well as by PDTC. Thus, indoxyl
sulfate-induced activation of NF-κB downregulates Nrf2
expression in HK-2 cells.
Indoxyl sulfate suppresses Nrf2 functions in rat kidneys
To confirm whether indoxyl sulfate reduces Nrf2 func-
tions in the kidney, the effect of indoxyl sulfate on the
expression of Nrf2 in the kidneys of normotensive and
hypertensive rats was determined in animal study 1. La-
boratory parameters of these rats including serum in-









































Figure 3 Knockdown of p65 alleviates indoxyl sulfate-induced decrease of Nrf2 in HK-2 cells. A: HK-2 cells were transfected with or
without NF-κB p65 siRNA (10 nM), and then serum starved for 24 h. Whole cell lysates were immunoblotted using anti-Nrf2 antibody. B: HK-2
cells were transfected with or without NF-κB p65 siRNA (10 nM), and then serum starved for 24 h, followed by indoxyl sulfate (250 μM) for 48 h.
Expression levels of Nrf2 mRNA were measured by real-time PCR. Data are expressed as mean±SE (n=4). *P < 0.05 vs. indoxyl sulfate-treated cells
without p65 siRNA. C: experimental conditions were as described in B except treatment with indoxyl sulfate for 72 h was used in place of 48 h.
Whole cell lysates were immunoblotted using anti-Nrf2 antibody.
Table 1 Serum levels of indoxyl sulfate at the 32nd
weeks of animal study 1 and at the 10th week of animal
study 2








CKD 0.52 ± 0.16*
CKD+AST-120 0.12±0.02#
Data are expressed as mean±SE (n=8 for animal study 1, or n=9 for animal
study 2).
**P < 0.01 vs. DN; ###P<0.001 vs. DH.
* P <0.05 vs. normal, # P <0.05 vs. CKD.
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lows; 143±3 mmHg in DN rats, 141±3 mmHg in DN+IS
rats, 158±5 mmHg in DH rats, and 158±9 mmHg in DH
+IS rats [6].
Expression levels of Nrf2, HO-1, and NQO1 were
reduced in DN+IS, DH and DH+IS rats as com-
pared with DN rats (Figures 4 and 5). On the other
hand, staining level of 8-OHdG, a ROS maker, was
increased in the kidneys of DN+IS, DH, and DH+IS
rats as compared with DN rats (Figures 4 and 5). In
addition, staining level of 8-OHdG in the kidneys of
DH+IS rats was significantly high as compared with
DH rats (Figures 4 and 5). Taken together, indoxyl
sulfate, as well as hypertension, suppresses Nrf2 ex-
pression in the kidney, followed by decreased ex-









Figure 4 Immunohistochemistry of Nrf2, HO-1, NQO1 and 8-OHdG in the kidneys of DN, DN+IS, DH, and DH+IS rats. Nrf2, HO-1 and
NQO1 were localized in the cytoplasm of tubular cells, especially in the kidneys of DN rats. 8-OHdG, a marker of ROS, was localized in the nuclei
of tubular cells, especially in the kidneys of DH+IS rats.
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rats by reducing serum level of indoxyl sulfate
The preset study investigates whether indoxyl sulfate in-
duces downregulation of Nrf2 expression in rat kidneys.

















































Figure 5 Immunostaining-positive areas of Nrf2, HO-1, NQO1 and 8-O
Immunostaining-positive areas of Nrf2, HO-1 and NQO1 were significantly d
the other hand, immunostaining-positive area of 8-OHdG was significantly
Data are expressed as mean±SE (n=8). **P < 0.01, ***P < 0.001 vs. DN; ###P<reduces the serum level of indoxyl sulfate, on the expres-
sion of Nrf2 in the kidneys of CKD rats was determined
in animal study 2. Laboratory parameters of these rats



















































HdG in the kidneys of DN, DN+IS, DH, and DH+IS rats.
ecreased in DN+IS, DH and DH+IS rats as compared with DN rats. On








Figure 6 Immunohistochemistry of Nrf2, HO-1, NQO1 and 8-OHdG in the kidneys of normal, CKD, and AST-120-treated CKD rats.
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thelial cells, including proximal and distal tubules
(Figure 6). In addition, positive staining for 8-OHdG was
localized in the nuclei of tubular epithelial cells. AST-
120 significantly stimulated Nrf2 expression in the
kidneys of CKD rats as compared with control CKD rats,


















































Figure 7 Immunostaining-positive areas of Nrf2, HO-1, NQO1 and 8-O
rats. Data are expressed as mean±SE (n=9). **P < 0.01, ***P < 0.001 vs. norcompared with normal rats (Figures 6 and 7). Further-
more, AST-120 significantly stimulated renal expression
of HO-1 and NQO1 as compared with control CKD rats,
although their expression levels were still reduced as com-
pared with normal rats (Figures 6 and 7). The staining
level of 8-OHdG was significantly diminished in the kid-



















































HdG in the kidneys of normal, CKD, and AST-120-treated CKD
mal rats; #P<0.05, ##P<0.01, ###P<0.001 vs. CKD rats.
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Nrf2 expression, followed by increased expression of HO-
1 and NQO1 and decreased level of ROS in the kidneys of
CKD rats as compared with control CKD rats.
Discussion
The novel findings of the present study are; 1) indoxyl
sulfate downregulated expression of Nrf2 in proximal
tubular cells, which was alleviated by an inhibitor of NF-κB
and siRNA specific to NF-κB p65, 2) indoxyl sulfate
downregulated expression of Nrf2, HO-1 and NQO1
and increased expression of 8-OHdG in rat kidneys,
and 3) AST-120 which reduced serum indoxyl sulfate,
upregulated expression of Nrf2, HO-1, and NQO1 and
decreased expression of 8-OHdG in CKD rat kidneys.
Thus, the indoxyl sulfate-induced downregulation of
Nrf2 leads to the downregulation of HO-1 and NQO1,
consequently followed by accumulation of 8-OHdG in
the kidneys.
The present study used two animal models. In animal
study 1, the effects of indoxyl sulfate administration on
Nrf2 expression in the kidneys of not only normal rats
but also hypertensive rats were determined, because
hypertension is often associated with CKD. In animal
study 2, the expression of Nrf2 in the kidney of CKD
rats was evaluated as compared with normal rats. Fur-
thermore, the effect of AST-120 on Nrf2 expression in
the kidneys of CKD rats was determined, because AST-
120 reduces serum indoxyl sulfate level and is clinically
used to treat CKD patients in Japan.
The present study first demonstrated that indoxyl sul-
fate downregulates Nrf2 expression in vitro and in vivo.
As a regulatory mechanism of Nrf2 expression, activated
Nrf2 binds to ARE sequence of its own promoter, and
thereby upregulates expression of Nrf2 itself [25]. Based
on this mechanism, we predict at least two regulatory
mechanisms by which indoxyl sulfate suppresses Nrf2
expression. One possibility is that indoxyl sulfate-induced
NF-κB activation inhibits Nrf2-ARE pathway because the
interaction of p65 with Keap1 promotes reduction of Nrf2
protein level through Nrf2 ubiquitination [26]. Another
possibility is that upregulation of p53 expression induced
by indoxyl sulfate-induced NF-κB activation is involved in
the suppression of Nrf2 mRNA expression, because p53
may bind to ARE sequences and thereby interfere inter-
action of Nrf2 with ARE sequences [27]. Furthermore,
suppression of HO-1 expression may be due to not only
downregulation of Nrf2 expression but also binding of
p53 to the ARE sequences of HO-1. Because we focused
on the crosstalk between indoxyl sulfate and Nrf2, expres-
sions of the NF-κB targets such as Keap1 and p53 are not
included in the present study,
The present study first demonstrated that AST-120 al-
leviates suppression of Nrf2 expression, and therebyinduces antioxidative effects in the kidneys of CKD rats.
Consequently, AST-120 relieves suppressed expression
of HO-1 and NQO1 and attenuates increase of ROS in
the CKD rat kidneys. ROS induces necrosis, apoptosis,
inflammation, and fibrosis, leading to dysfunction of
renal proximal tubular cells. Accumulating evidence indi-
cates that increased humoral factors such as interleukin-6,
tumor necrosis factor-α, and angiotensin II induce ROS in
CKD rat kidney. Therefore, ROS-induced dysfunction of
kidney by these humoral factors also might be suppressed
by AST-120 through upregulation of Nrf2 function in the
kidney.
Recently, bardoxolone methyl, an activator of Nrf2,
has been reported to attenuate progression of CKD and
diabetic nephropathy [28,29]. We consider that indoxyl
sulfate might contribute to the progression of CKD pa-
tients by downregulating renal expression of Nrf2.
Conclusion
Indoxyl sulfate downregulates renal expression of Nrf2
through activation of NF-κB, followed by downregulation
of HO-1 and NQO1 and increased production of ROS.
Further, AST-120 upregulates renal expression of Nrf2 in
CKD rats by removing serum indoxyl sulfate, followed by
upregulation of HO-1 and NQO1 and decreased produc-
tion of ROS.
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